Seroatlas · Human Serome Atlas

SLC17A9

Voltage-gated purine nucleotide uniporter SLC17A9

Also known as: C20orf59, FLJ23412, S17A9_HUMAN, VNUT

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
Q9BYT1
Gene
SLC17A9
Ensembl
ENSG00000101194
Chromosome
20
Canonical length
436 aa
Protein class
Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters
Subcellular location
Nucleoplasm

OverviewNCBI Gene

This gene encodes a member of a family of transmembrane proteins that are involved in the transport of small molecules. The encoded protein participates in the vesicular uptake, storage, and secretion of adenoside triphosphate (ATP) and other nucleotides. A mutation in this gene was found in individuals with autosomal dominant disseminated superficial actinic porokeratosis-8. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Nov 2014]

Canonical amino-acid sequenceUniProt

436 residues, UniProt reviewed canonical sequence.

>Q9BYT1|SLC17A9
     1  MQPPPDEARR DMAGDTQWSR PECQAWTGTL LLGTCLLYCA RSSMPICTVS MSQDFGWNKK
    61  EAGIVLSSFF WGYCLTQVVG GHLGDRIGGE KVILLSASAW GSITAVTPLL AHLSSAHLAF
   121  MTFSRILMGL LQGVYFPALT SLLSQKVRES ERAFTYSIVG AGSQFGTLLT GAVGSLLLEW
   181  YGWQSIFYFS GGLTLLWVWY VYRYLLSEKD LILALGVLAQ SRPVSRHNRV PWRRLFRKPA
   241  VWAAVVSQLS AACSFFILLS WLPTFFEETF PDAKGWIFNV VPWLVAIPAS LFSGFLSDHL
   301  INQGYRAITV RKLMQGMGLG LSSVFALCLG HTSSFCESVV FASASIGLQT FNHSGISVNI
   361  QDLAPSCAGF LFGVANTAGA LAGVVGVCLG GYLMETTGSW TCLFNLVAII SNLGLCTFLV
   421  FGQAQRVDLS STHEDL

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against SLC17A9 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Other membrane
Secreted
No
Transmembrane segments
10
Mean surface accessibility (rSASA)
0.24
Highest tissue expression
39 nTPM

Expression across tissuesHPA

Tissue

  • liver: 39 nTPM
  • bone marrow: 11 nTPM
  • spleen: 10 nTPM
  • stomach: 9 nTPM
  • appendix: 5.4 nTPM
  • duodenum: 5.1 nTPM

Single-cell type

  • hepatocytes: 62 nCPM
  • plasma cells: 50 nCPM
  • hofbauer cells: 21 nCPM
  • hematopoietic stem cells: 21 nCPM
  • goblet cells: 18 nCPM
  • foveolar cells: 17 nCPM

Immune cell

  • NK-cell: 4.9 nTPM
  • myeloid DC: 2.6 nTPM
  • memory B-cell: 2.2 nTPM
  • intermediate monocyte: 1.7 nTPM
  • naive B-cell: 1.7 nTPM
  • classical monocyte: 0.9 nTPM

Brain region

  • white matter: 4.2 nTPM
  • medulla oblongata: 2.9 nTPM
  • thalamus: 2.7 nTPM
  • pons: 2.6 nTPM
  • cerebral cortex: 2.2 nTPM
  • spinal cord: 2.2 nTPM

DiseaseUniProt · ClinVar · IEDB · PubMed

Four sources answering four different questions about SLC17A9.

Disease | AllUniProt

Conditions SLC17A9 is implicated in, by any mechanism.

Disease | GeneticClinVar

1 pathogenic / likely-pathogenic of 114 ClinVar records.

Conditions with pathogenic or likely-pathogenic variants.

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
1.39
gnomAD pLI
0
gnomAD missense Z
1.29
DepMap mean gene effect
0.08
DepMap dependency class
selective

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 8% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Molecular functions

Cellular components

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads SLC17A9 as an antibody target. Whether an autoantibody or antibody against SLC17A9 could matter depends on whether native SLC17A9 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

SLC17A9 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.

Annotation status

The present source text does not explicitly label SLC17A9 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/SLC17A9. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...